NO130824B - - Google Patents
Download PDFInfo
- Publication number
- NO130824B NO130824B NO03902/69A NO390269A NO130824B NO 130824 B NO130824 B NO 130824B NO 03902/69 A NO03902/69 A NO 03902/69A NO 390269 A NO390269 A NO 390269A NO 130824 B NO130824 B NO 130824B
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- dione
- hydroxy
- chlorine
- fluorine
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 7
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 239000011737 fluorine Substances 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 5
- 229910000040 hydrogen fluoride Inorganic materials 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000004593 Epoxy Substances 0.000 claims description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- -1 chloro- Chemical class 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 235000011056 potassium acetate Nutrition 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 201000009053 Neurodermatitis Diseases 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- ASZZHBXPMOVHCU-UHFFFAOYSA-N 3,9-diazaspiro[5.5]undecane-2,4-dione Chemical compound C1C(=O)NC(=O)CC11CCNCC1 ASZZHBXPMOVHCU-UHFFFAOYSA-N 0.000 description 1
- 241000252073 Anguilliformes Species 0.000 description 1
- QIEPWCSVQYUPIY-LEKSSAKUSA-N Delta(1)-progesterone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 QIEPWCSVQYUPIY-LEKSSAKUSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 206010064000 Lichenoid keratosis Diseases 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- TXHIDIHEXDFONW-UHFFFAOYSA-N benzene;propan-2-one Chemical compound CC(C)=O.C1=CC=CC=C1 TXHIDIHEXDFONW-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19681801390 DE1801390C3 (de) | 1968-10-02 | 6,9,21-Trihalogensteroide, Verfahren zu deren Herstellung, diese enthaltende Arzneimittel und 6,21-Dihalogen-Zwischenprodukte |
Publications (2)
Publication Number | Publication Date |
---|---|
NO130824B true NO130824B (nl) | 1974-11-11 |
NO130824C NO130824C (nl) | 1975-02-19 |
Family
ID=5709719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO3902/69A NO130824C (nl) | 1968-10-02 | 1969-10-01 |
Country Status (16)
Country | Link |
---|---|
AT (1) | AT290033B (nl) |
BE (1) | BE739736A (nl) |
BR (1) | BR6912959D0 (nl) |
CH (1) | CH540891A (nl) |
CS (1) | CS150285B2 (nl) |
DK (1) | DK121053B (nl) |
ES (1) | ES372061A1 (nl) |
FI (1) | FI46505C (nl) |
FR (1) | FR2019676A1 (nl) |
GB (1) | GB1286659A (nl) |
IE (1) | IE33329B1 (nl) |
IL (1) | IL33017A (nl) |
NL (1) | NL167439C (nl) |
NO (1) | NO130824C (nl) |
RO (1) | RO54664A (nl) |
SE (1) | SE352082B (nl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2010458B2 (de) * | 1970-02-28 | 1979-04-26 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue 21-Halogensteroide |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3499016A (en) * | 1958-08-04 | 1970-03-03 | Upjohn Co | 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series |
-
1969
- 1969-09-15 RO RO61035A patent/RO54664A/ro unknown
- 1969-09-17 IL IL33017A patent/IL33017A/xx unknown
- 1969-09-22 CH CH1427369A patent/CH540891A/de not_active IP Right Cessation
- 1969-09-30 ES ES372061A patent/ES372061A1/es not_active Expired
- 1969-09-30 IE IE1363/69A patent/IE33329B1/xx unknown
- 1969-09-30 GB GB48004/69A patent/GB1286659A/en not_active Expired
- 1969-10-01 SE SE13534/69A patent/SE352082B/xx unknown
- 1969-10-01 DK DK523169AA patent/DK121053B/da not_active IP Right Cessation
- 1969-10-01 CS CS6578A patent/CS150285B2/cs unknown
- 1969-10-01 AT AT928069A patent/AT290033B/de not_active IP Right Cessation
- 1969-10-01 FR FR6933482A patent/FR2019676A1/fr not_active Withdrawn
- 1969-10-01 NO NO3902/69A patent/NO130824C/no unknown
- 1969-10-02 NL NL6914942.A patent/NL167439C/nl not_active IP Right Cessation
- 1969-10-02 BE BE739736D patent/BE739736A/xx unknown
- 1969-10-02 FI FI692843A patent/FI46505C/fi active
- 1969-10-02 BR BR212959/69A patent/BR6912959D0/pt unknown
Also Published As
Publication number | Publication date |
---|---|
IL33017A (en) | 1974-01-14 |
NO130824C (nl) | 1975-02-19 |
BR6912959D0 (pt) | 1973-02-08 |
CH540891A (de) | 1973-08-31 |
AT290033B (de) | 1971-05-10 |
IL33017A0 (en) | 1969-11-30 |
RO54664A (nl) | 1973-03-15 |
ES372061A1 (es) | 1971-09-01 |
FR2019676A1 (nl) | 1970-07-03 |
NL167439C (nl) | 1981-12-16 |
IE33329B1 (en) | 1974-05-29 |
IE33329L (en) | 1970-04-02 |
DE1801390B2 (de) | 1977-02-17 |
DK121053B (da) | 1971-08-30 |
BE739736A (nl) | 1970-04-02 |
DE1801390A1 (de) | 1970-05-21 |
NL6914942A (nl) | 1970-04-06 |
FI46505C (fi) | 1973-04-10 |
SE352082B (nl) | 1972-12-18 |
NL167439B (nl) | 1981-07-16 |
FI46505B (fi) | 1973-01-02 |
GB1286659A (en) | 1972-08-23 |
CS150285B2 (nl) | 1973-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6354391A (ja) | ステロイドの製法 | |
NO791365L (no) | Corticoid-17-alkylkarbonater og fremgangsmaate til deres fremstilling | |
EP0100874B1 (de) | Neue 6,16-Dimethylkortikoide, ihre Herstellung und Verwendung | |
JPS595600B2 (ja) | D − ホモステロイド ノ セイゾウホウホウ | |
NO154268B (no) | Analogifremgangsmùte ved fremstilling av nye terapeutisk a ktive 6a-fluor-9a-klor-prednisolon-17,21-diestere. | |
EP0061416B1 (en) | Process for the preparation of delta 9(11)- and delta 16-21-chloro-20-keto steroids of the pregnane and d-homopregnane series and their use as intermediates for the synthesis of highly effective corticoids | |
US2838536A (en) | 6-fluoro 9 alpha-halo-delta4-pregnenes and process for preparing same | |
NO743447L (nl) | ||
NO130824B (nl) | ||
CH632279A5 (en) | Process for the preparation of polyhalogenated steroids | |
JPH0564158B2 (nl) | ||
US2867633A (en) | 11-oxygenated-6-methyl-17alpha-hydroxy-4-pregnene-3, 20-diones | |
US2838541A (en) | 6-fluoro-4-pregnenes and process for preparing same | |
US3076823A (en) | Process for the production of 6-chloro-3-keto-deta steroid compounds | |
US2691029A (en) | Steroid oxidation | |
US2884421A (en) | 6-fluoro-17alpha, 21-epoxy-4-pregnenes | |
NO154583B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17-substitiuerte 11beta-hydroxysteroider av pregnanrekken. | |
NO154759B (no) | Fremgangsmaate til overflatebehandling av et arbeidsstykke av en nikkelsuperlegering, samt etsemiddel til utoevelse av fremgangsmaaten. | |
US3684674A (en) | Process for preparing 18-cyano-pregnane compounds | |
US3182075A (en) | 17-substituted 19-norpregna-1, 3, 5(10), 6, 8-pentaen-20-ones | |
US3022323A (en) | Y-substituted thio steroids of the | |
US3819604A (en) | 6,9,21-trihalogenosteroids | |
US2888473A (en) | Brominated derivatives of compounds of the pregnane series and methods of making same | |
US2963496A (en) | 9 alpha-halo-16-dehydro steroids of the pregnane series | |
US3489748A (en) | 16alpha-thio-9beta,10alpha-delta**4-pregnene - 3 - ones and intermediates in the preparation thereof |